GSK933776
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for GSK933776, covering 2017-05-05 to 2017-07-21. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease [Phase 1]